Corpus Intelligence IC Memo — KFH - WOODLAND HILLS 2026-04-26 11:55 UTC
IC Memo — KFH - WOODLAND HILLS
Investment Committee Memorandum | CA | 274 beds | Grade C | EBITDA uplift $29.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KFH - WOODLAND HILLS

CCN 050677 | LOS ANGELES, CA | 274 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KFH - WOODLAND HILLS is a 274-bed suburban community hospital in LOS ANGELES, CA with $405.1M in net patient revenue and a -11.4% operating margin. The hospital serves a payer mix of 3.9% Medicare, 0.7% Medicaid, and 95.5% commercial.

Thesis: Undervalued. Our ML models identify $29.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.4% to -4.0% (+736bps).

Net Revenue HCRIS$405.1M
Current EBITDA COMPUTED$-46.0M
Operating Margin COMPUTED-11.4%
Occupancy HCRIS39.6%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS26.4%
Distress Probability ML48.4%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
188
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -11.4% places it below the state median. Among 188 size-comparable peers (137-548 beds), the median margin is -3.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (137-548), prioritizing same-state peers. 188 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KFH - WOODLAND HILLS (Target)CA274$405.1M-11.4%
RONALD REAGAN UCLACA446$2.62B-6.8%
LUCILE PACKARD CHILDRENS HOSPICA394$2.39B-0.8%
UCI MEDICAL CENTERCA397$1.90B-2.5%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
RADY CHILDRENS HOSPITAL - SAN CA401$1.82B14.8%
HARBOR-UCLA MEDICAL CENTERCA369$1.54B-6.4%
HOAG MEMORIAL HOSPITAL PRESBYTCA512$1.37B-3.9%
SUTTER MEDICAL CENTER - SACRAMCA523$1.36B0.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $29.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.5M+210bp18mo
Cost to Collect4.5%2.5%$8.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$8.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.9M+122bp9mo
Clean Claim Rate88.0%96.0%$259K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.5M
Cost to Collect
$8.1M
Denial Rate Reduction
$8.0M
A/R Days Reduction
$4.9M
Clean Claim Rate
$259K
Total EBITDA Uplift$29.8M
Current EBITDA$-46.0M
+ RCM Uplift+$29.8M
Pro Forma EBITDA$-16.2M
Current Margin-11.4%
Pro Forma Margin-4.0%
WC Released (1x)$15.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-70.8M$-5.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-70.8M$-28.7M0.00x-100.0%
Bull Case9.0x11.0x$-63.7M$46.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-63.7M$32.2M0.00x-100.0%
Bear Case11.0x10.0x$-77.8M$-131.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-77.8M$-169.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 188 hospitals with 137-548 beds
  • Same-state prioritization (n=189)
  • Comp margins: P25=-15.5% / P50=-3.9% / P75=4.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.